Awarded contractOpenSuppliesPoland
Dostawa produktów leczniczych: 1. Niwolumab + Relatlimab; 2. Tepotynib, nr PN-110/24/TM
1 supplier awarded•2 lots awarded•€17.06M awarded
Buyer: Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy / Warszawa, Poland
Published Jul 17, 2024Awarded Jun 30, 2024
Various medicinal products
Awarded value
€17.06M
Estimated value
€17.06M
Awarded at 100% of estimated value
Award date
Jun 30, 2024
Winners
1
Lots awarded
2
Winners
URTICA Sp. z o.o.
2 lotsWrocław, POL
€17.1M This contract
499 award notices•1,666 awarded lots•€342.93M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | URTICA Sp. z o.o. | €16.9M | Various medicinal products (33690000) | |
| LOT-0002 | URTICA Sp. z o.o. | €121,852 | Various medicinal products (33690000) |